AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F398-F407, 2007. First published April 11, 2007; doi:10.1152/ajprenal.00050.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
293/1/F398    most recent
00050.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velez, J. C. Q.
Right arrow Articles by Janech, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velez, J. C. Q.
Right arrow Articles by Janech, M. G.

Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes

Juan Carlos Q. Velez,1,2 Alison M. Bland,2 John M. Arthur,1,2 John R. Raymond,1,2 and Michael G. Janech2

1Department of Research, Ralph H. Johnson Veterans Affairs Medical Center, and 2Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina

Submitted 1 February 2007 ; accepted in final form 5 April 2007

Intraglomerular ANG II has been linked to glomerular injury. However, little is known about the contribution of podocytes (POD) to intraglomerular ANG II homeostasis. The aim of the present study was to examine the processing of angiotensin substrates by cultured POD. Our approach was to use matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for peptide determination from conditioned cell media and customized AQUA peptides for quantification. Immortalized mouse POD were incubated with 1-2 µM ANG I, ANG II, or the renin substrate ANG-(1-14) for different time intervals and coincubated in parallel with various inhibitors. Human mesangial cells (MES) were used as controls. POD incubated with 1 µM ANG I primarily formed ANG-(1-9) and ANG-(1-7). In contrast, MES incubated with ANG I primarily generated ANG II. In POD, ANG-(1-7) was the predominant product, and its formation was inhibited by a neprilysin inhibitor. Modest angiotensin-converting enzyme (ACE) activity was also detected in POD, although only after cells were incubated with 2 µM ANG I. In addition, we observed that POD degraded ANG II into ANG III and ANG-(1-7). An aminopeptidase A inhibitor inhibited ANG III formation, and an ACE2 inhibitor led to ANG II accumulation. Furthermore, we found that POD converted ANG-(1-14) to ANG I and ANG-(1-7). This conversion was inhibited by a renin inhibitor. These findings demonstrate that POD express a functional intrinsic renin-angiotensin system characterized by neprilysin, aminopeptidase A, ACE2, and renin activities, which predominantly lead to ANG-(1-7) and ANG-(1-9) formation, as well as ANG II degradation. These findings may reflect a specific role of POD in maintenance of intraglomerular renin-angiotensin system balance.

angiotensin II; angiotensin-(1-7); neprilysin; ACE2; aminopeptidase A



Address for reprint requests and other correspondence: J. C. Q. Velez, Division of Nephrology, Dept. of Medicine, Medical Univ. of South Carolina, 96 Jonathan Lucas St., Clinical Science Bldg. Rm. 829, Charleston, SC 29425 (e-mail: velezj{at}musc.edu)




This article has been cited by other articles:


Home page
HypertensionHome page
J. C. Q. Velez, K. J. Ryan, C. E. Harbeson, A. M. Bland, M. N. Budisavljevic, J. M. Arthur, W. R. Fitzgibbon, J. R. Raymond, and M. G. Janech
Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli
Hypertension, May 1, 2009; 53(5): 790 - 797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Burns and N. Li
Letter to the Editor
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F666 - F666.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
M. J. Soler, J. Wysocki, and D. Batlle
Angiotensin-converting enzyme 2 and the kidney
Exp Physiol, May 1, 2008; 93(5): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Whaley-Connell, J. Habibi, R. Nistala, S. A. Cooper, P. R. Karuparthi, M. R. Hayden, N. Rehmer, V. G. DeMarco, B. T. Andresen, Y. Wei, et al.
Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment
Hypertension, February 1, 2008; 51(2): 474 - 480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.